The Rehabilitation Enhancing Aging Through Connected Health Prehabilitation Trial.


Journal

Archives of physical medicine and rehabilitation
ISSN: 1532-821X
Titre abrégé: Arch Phys Med Rehabil
Pays: United States
ID NLM: 2985158R

Informations de publication

Date de publication:
11 2019
Historique:
received: 01 03 2019
revised: 11 04 2019
accepted: 26 04 2019
pubmed: 4 6 2019
medline: 19 3 2020
entrez: 2 6 2019
Statut: ppublish

Résumé

To evaluate the proof of concept of an innovative model of physical therapy Rehabilitation Enhancing Aging through Connected Health (REACH) and evaluated its feasibility and effect on physical function and health care utilization. Quasi-experimental 12-month clinical trial. Two outpatient rehabilitation centers. Community-dwelling older primary care patients with a treatment arm undergoing the intervention (n=75; mean age=77±5.9y; 54% women) and propensity matched controls derived from a longitudinal cohort study (n=430; mean age=71±7.0y; 68% women) using identical recruitment criteria (N=505). Combined outpatient and home PT augmented with a commercially available app and computer tablet. Primary outcomes included a feasibility questionnaire, exercise adherence, self-reported function, and the Short Physical Performance Battery (SPPB). Secondary outcomes included the rates of emergency department (ED) visits and hospitalizations. Among REACH participants, we observed a 9% dropout rate. After accounting for dropouts, with propensity matching, n=68 treatments and n=100 controls were analyzed. Over the 12-month study duration, 85% of participants adhered to the exercise program an average of 2 times a week and evaluated the treatment experience favorably. In comparison to controls, after 1 year of treatment and within multivariable regression models, REACH participants did not manifest a significant difference in patient reported function (group x time effect 1.67 units, P=.10) but did manifest significant differences in SPPB (group x time effect 0.69 units, P=.03) and gait speed (group x time effect .08m/s, P=.02). In comparison to controls, after 1 year, the rate of ED visits (group x time treatment rate=0.27, P<.004) were significantly reduced, but a significant reduction in hospitalizations was not observed. The REACH intervention is feasible and has proof of concept in preventing functional decline and favorably affecting health care utilization. Evaluation on a larger scale is warranted.

Identifiants

pubmed: 31152705
pii: S0003-9993(19)30380-6
doi: 10.1016/j.apmr.2019.04.015
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02580409']

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1999-2005

Subventions

Organisme : NIA NIH HHS
ID : R01 AG032052
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Auteurs

Jonathan F Bean (JF)

New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA; Harvard Medical School, Boston, MA; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA. Electronic address: Jonathan.bean4@va.gov.

Lorna Brown (L)

Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA.

Tamara R DeAngelis (TR)

College of Health and Rehabilitation Sciences: Sargent, Boston University, Boston, MA.

Terry Ellis (T)

College of Health and Rehabilitation Sciences: Sargent, Boston University, Boston, MA.

V S Senthil Kumar (VSS)

Heller School for Social Policy and Management, Brandeis University, Waltham, MA.

Nancy K Latham (NK)

New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Danielle Lawler (D)

Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA.

Meng Ni (M)

Bloomsburg University of Pennsylvania, Bloomsburg, PA.

Jennifer Perloff (J)

Heller School for Social Policy and Management, Brandeis University, Waltham, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH